Atrial Fibrillation | UMCG | Ongoing research-initiated by others
16428
portfolio_page-template-default,single,single-portfolio_page,postid-16428,ajax_fade,page_not_loaded,,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-4.12,vc_responsive

Ongoing research-initiated by others

Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy (AXAFA) study

Prof.dr. Van Gelder is member of the steering committee and national coordinator, dr. Rienstra is local investigator at UMCG.

ClinicalTrials.gov Identifier: NCT02227550

Sponsor: German Atrial Fibrillation Competence NETwork (AFNET)

 

Early Treatment of Atrial Fibrillation for Stroke Prevention Trial (EAST) study

ClinicalTrials.gov Identifier: NCT01288352

Prof.dr. Van Gelder is member of the steering committee and national coordinator, dr. Rienstra is local investigator at UMCG.

Sponsor: German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA), a branch of the European Society of Cardiology (ESC)

 

A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure (GENETIC-AF) study

Prof.dr. Van Veldhuisen is member of the steering committee, dr. Rienstra is national coordinator.

ClinicalTrials.gov Identifier: NCT01970501

Sponsor: ARCA biopharma, Inc.